Blinatumomab
Formulations: - Parenteral > General injections > IV: 35 µg in vial; 38.5 µg in vial Indications: - B lymphoblastic leukaemia or lymphoma, not elsewhere classified Source: EML workbook import
MOQ: 1
Kes0.00
Product image unavailable
Atezolizumab
Vendor: Marketplace supplier
Formulations:
- Parenteral > General injections > IV: 1.2 g per 20 mL concentrate solution for infusion
Parenteral > General injections > IV: 840 mg per 14 mL in vial concentrate for solution for infusion; 1200 mg per 20 mL in vial concentrate for solution for infusion
Indications:
- Other specified malignant neoplasms of bronchus or lung
- Adenocarcinoma of stomach
Source: EML workbook import
Product metadata will be available once the catalog entry is complete.
Kes0.00
Availability
Supplier and price will be confirmed during RFQ.
Formulations:
- Parenteral > General injections > IV: 1.2 g per 20 mL concentrate solution for infusion
Parenteral > General injections > IV: 840 mg per 14 mL in vial concentrate for solution for infusion; 1200 mg per 20 mL in vial concentrate for solution for infusion
Indications:
- Other specified malignant neoplasms of bronchus or lung
- Adenocarcinoma of stomach
Source: EML workbook import
Similar Products
Cemiplimab
Formulations: - Parenteral > General injections > IV: 50 mg per mL in 7 mL vial concentrate for solution for infusion Indications: - Other specified malignant neoplasms of bronchus or lung Source: EML workbook import
MOQ: 1
Kes0.00
Filgrastim
Formulations: - Parenteral > General injections > SC: 120 µg per 0.2 mL in prefilled syringe; 300 µg per 0.5 mL in prefilled syringe; 480 µg per 0.8 mL in prefilled syringe; 300 µg per mL in 1 mL vial; 480 µg per 1.6 mL in 1.6 mL vial Indications: - Acquired neutropaenia Source: EML workbook import
MOQ: 1
Kes0.00
Lenalidomide
Formulations: - Oral > Solid: 25 mg Indications: - Plasma cell myeloma Source: EML workbook import
MOQ: 1
Kes0.00
Nivolumab
Formulations: - Parenteral > General injections > IV: 10 mg per mL concentrate solution for infusion Parenteral > General injections > IV: 10 mg per mL in 4 mL vial concentrate solution for infusion; 10 mg per mL in 10 mL vial concentrate solution for infusion; 10 mg per mL in 12 mL vial concentrate solution for infusion; 10 mg per mL in 24 mL vial concentrate solution for infusion Parenteral > General injections > IV: 10 mg per mL in 24 mL vial concentrate solution for infusion; 10 mg per mL in 4 mL vial concentrate solution for infusion; 10 mg per mL in 10 mL vial concentrate solution for infusion; 10 mg per mL in 12 mL vial concentrate solution for infusion Indications: - Other specified malignant neoplasms of bronchus or lung - Melanoma of skin - Renal cell carcinoma of kidney, except renal pelvis - Squamous cell carcinoma of oesophagus - Adenocarcinoma of oesophagogastric junction - Adenocarcinoma of stomach Source: EML workbook import
MOQ: 1
Kes0.00
Pegfilgrastim
Formulations: - Parenteral > General injections > SC: 6 mg per 0.6 mL in pre-filled syringe Indications: - Acquired neutropaenia Source: EML workbook import
MOQ: 1
Kes0.00
Sign Up to Our Newsletter→
Ready to amplify your rewards? Drop your email and we'll be in touch soon.